UTIPRO® PLUS

Uro-ginecology Scientific Publication UTIPRO® PLUS

Uncomplicated Urinary Tract Infection in Adults - Noventure new Publication

We are glad inform you about a recent publication to further support the usefulness of mucoprotection in the relief of symptoms and in the prevention of recurrences in uncomplicated UTIs The trial "Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults" has been published on Urologia Internationalis. https://www.ncbi.nlm.nih.gov/pubmed/30889607 In the study, safety and efficacy of a Xyloglucan based medical device were investigated as adjuvant therapy to first-line antimicrobials for treatment of uncomplicated UTIs in adults.

Uro-ginecology News UTIPRO® PLUS

News on NOVENTURE participation at EAU 2019 in BARCELONA

For the fourth consecutive year, Noventure was present at the annual congress of the EAU - European Association of Urology- that took place in Barcelona 15th – 19th March 2019. Noventure participation to EAU is to confirm its presence in the urology field with its medical device for oral use UTIPRO PLUS intended to control and prevent uncomplicated UTIs.

Uro-ginecology News UTIPRO® PLUS

Noventure's Participation in 2018 EAU congress

For the third consecutive year, Noventure has participated in the annual congress of the EAU - European Association of Urology that took place in Copenhagen 17th – 19th March 2018 with about 11,000 participants, coming from 123 countries all over the world. During the Congress 273 scientific sessions included 2,656 presentations of cutting-edge urological updates presented by 1,830 international experts. Noventure participated in this congress with a 28 m2 stand to assess its presence in the urology field thanks to its medical device UTIPRO PLUS intended to control and prevent uncomplicated UTIs.